Jim Bishop Email & Phone Number

Cambridge, Massachusetts, Us

Cambridge, Massachusetts, Us

Led integration and restructuring initiatives in the combination of Altavant and Enzyvant including strategy development, vision, culture, and values alignment, legal, and third-party relationship management for more than 300 vendors and consultants. Oversaw facilities, technology, human resources, and program management for restructured organization with >$100M budget and projected >120 staff. Reported to the CEO and provided strategic direction to Vice President Program and Portfolio Management, Senior Director Government Relations and Patient Advocacy, and Director Human Resources.

Led FP&A and accounting teams for $50M+ budget across R&D (clinical, nonclinical, regulatory, manufacturing) and G&A. Oversaw legal, HR, IT, and facility functions, and served as Compliance Officer and Head of Quality. Reported to the COO and provided strategic direction to Vice President Program and Portfolio Management, Controller, and Senior Accountant.

Directed technology, finance, project management, legal, IP, and human resource operational initiatives. Oversaw FP&A for $40M annual budget, facilitated formation of new Altavant subsidiary, and led integration activities.

New York, New York, Us

Led rapid growth and development initiatives to scale team from 25 to 125 scientists and drug development professionals and coordinate due diligence teams for in-licensing and new asset acquisitions. Responsible for HR initiatives, talent deployment, and restructuring during reorganization. Reported to the Chief Development Officer.

Tel-Aviv, Il

Spearheaded financial planning and tracking for $20M project budget. Led planning and execution of pharmacogenetics (PGx), biomarker, digital health, and wearable sensor projects. Implemented program and project management methodology for key portfolio assets and coordinated clinical study activities related to personalized medicine.

Provided Project Management expertise to pharmaceutical and biotechnology companies with the specific focus on integration of pharmacogenetics (PGx) to reduce R&D pipeline attrition, moderate development costs, strengthen regulatory filings, enhance market acceptance, improve pharmacovigilance—and, ultimately, to give physicians greater confidence in the use of products and provide patients surer benefit. Assigned as embedded consultant in Tailored Therapeutics team at Eli Lilly

Chapel Hill, North Carolina, Us

Directed all preclinical operations for the research and development of drug products (intravenous and topical) and medical devices for the treatment of traumatic brain injury, spinal cord injury, wounds and other dermatological indications. Secured R&D funding and support through government grants and collaborative partnerships.

Chapel Hill, North Carolina, Us

Brentford, Middlesex, Gb

Supported all activities for assigned projects within Drug Metabolism and Pharmacokinetics (DMPK), including preparing and maintaining detailed project plans and budgets, coordinating preclinical studies and clinical support, and drafting sections of regulatory documents for FDA and EMEA. Directed studies in the areas of in vitro metabolism, in vivo excretion balance, and metabolite profiling and quantitation. Evaluated and established new techniques to aid in predicting absorption and metabolism of new chemical entities

Brentford, Middlesex, Gb

Coordinated antiviral and metabolic projects in DMPK from pre-candidate selection through Phase 2 clinical development, including Alliance projects (in-license and joint venture) with Japanese companies

Bachelor Of Science - Bs, Biochemistry

Master Of Business Administration - Mba